UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2years of treatment in children with secondary osteoporosis

Bone (New York, N.Y.), 2011-11, Vol.49 (5), p.939-943

2011

Volltextzugriff (PDF)

Zoledronic acid improves bone mineral density in pediatric spinal cord injury

Journal of bone and mineral research, 2012-07, Vol.27 (7), p.1536-1540

2012

Volltextzugriff (PDF)

Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis

Bone (New York, N.Y.), 2011-11, Vol.49 (5), p.939-943

2011

Volltextzugriff (PDF)

Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg–Calve–Perthes disease

Bone (New York, N.Y.), 2009-11, Vol.45 (5), p.898-902

2009

Volltextzugriff (PDF)

Acute phase response and mineral status following low dose intravenous zoledronic acid in children

Bone (New York, N.Y.), 2007-09, Vol.41 (3), p.366-370

2007

Volltextzugriff (PDF)

Short-term safety assessment in the use of intravenous zoledronic acid in children

The Journal of pediatrics, 2004-11, Vol.145 (5), p.701-704

2004

Volltextzugriff (PDF)

Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2<ce:hsp sp="0.25"/>years of treatment in children with secondary osteoporosis

Bone (New York, N.Y.), 2011-11, Vol.49 (5), p.939-943

2011

Volltextzugriff (PDF)

Use of bisphosphonates in a case of Perthes disease

Orthopaedic nursing, 2005-11, Vol.24 (6), p.393-398

2005

Volltextzugriff (PDF)

Long-term effects of bisphosphonate therapy in children with osteogenesis imperfecta

Bone Abstracts, 2013-06

2013

Volltextzugriff (PDF)

Reduction in bisphosphonate side effect profile using short-term steroid cover

Bone Abstracts, 2013-06

2013

Volltextzugriff (PDF)

Class Act for Business

Canadian banker (1983), 1984-08, Vol.91 (4), p.26

McQuade, Mary Fran

1984

Volltextzugriff (PDF)

A survey of chronic disease by means of the Szondi test

McQuade, Mary Margaret

1951

Volltextzugriff (PDF)

A survey of chronic disease by means of the Szondi test

McQuade, Mary Margaret

1951

Volltextzugriff (PDF)

Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials

The American journal of geriatric psychiatry, 2020-04, Vol.28 (4), p.383-400

2020

Volltextzugriff (PDF)

Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial

The American journal of psychiatry, 2015-09, Vol.172 (9), p.870-880

2015

Volltextzugriff (PDF)

Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study

The journal of clinical psychiatry, 2015-09, Vol.76 (9), p.1232-1240

2015

Volltextzugriff (PDF)

A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Fixed-Dose Brexpiprazole 2 mg/d as Adjunctive Treatment of Adults With Major Depressive Disorder

The journal of clinical psychiatry, 2018-05, Vol.79 (4)

2018

Volltextzugriff (PDF)

Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants

The journal of clinical psychiatry, 2015-09, Vol.76 (9), p.1224-1231

2015

Volltextzugriff (PDF)

A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia

Schizophrenia research, 2015-05, Vol.164 (1), p.127-135

2015

Volltextzugriff (PDF)

A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder

Journal of clinical psychopharmacology, 2019-05, Vol.39 (3), p.203-209

2019

Volltextzugriff (PDF)

Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study

Current medical research and opinion, 2018-04, Vol.34 (4), p.633-642

2018

Volltextzugriff (PDF)

Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study

The international journal of neuropsychopharmacology, 2017-01, Vol.20 (1), p.11-21

2017

Volltextzugriff (PDF)

Outcomes of World Health Organization-defined Severe Respiratory Distress without Shock in Adults in Sub-Saharan Africa

American journal of respiratory and critical care medicine, 2024-01, Vol.209 (1), p.109-112

2024

Volltextzugriff (PDF)

Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy

The New England journal of medicine, 2013-11, Vol.369 (20), p.1892-1903

2013

Volltextzugriff (PDF)

A remote monitoring-enabled home exercise prescription for patients with interstitial lung disease at risk for exercise-induced desaturation

Respiratory medicine, 2023-11, Vol.218, p.107397-107397, Article 107397

2023

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(47)
Dissertationen
(2)

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2years of treatment in children with secondary osteoporosis

Zoledronic acid improves bone mineral density in pediatric spinal cord injury

Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2 years of treatment in children with secondary osteoporosis

Systemic effects of zoledronic acid in children with traumatic femoral head avascular necrosis and Legg–Calve–Perthes disease

Acute phase response and mineral status following low dose intravenous zoledronic acid in children

Short-term safety assessment in the use of intravenous zoledronic acid in children

Zoledronic acid improves bone mineral density, reduces bone turnover and improves skeletal architecture over 2<ce:hsp sp="0.25"/>years of treatment in children with secondary osteoporosis

Use of bisphosphonates in a case of Perthes disease

Long-term effects of bisphosphonate therapy in children with osteogenesis imperfecta

Reduction in bisphosphonate side effect profile using short-term steroid cover

Class Act for Business

A survey of chronic disease by means of the Szondi test

A survey of chronic disease by means of the Szondi test

Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials

Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial

Adjunctive brexpiprazole 1 and 3 mg for patients with major depressive disorder following inadequate response to antidepressants: a phase 3, randomized, double-blind study

A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Fixed-Dose Brexpiprazole 2 mg/d as Adjunctive Treatment of Adults With Major Depressive Disorder

Efficacy and safety of adjunctive brexpiprazole 2 mg in major depressive disorder: a phase 3, randomized, placebo-controlled study in patients with inadequate response to antidepressants

A multicenter, randomized, double-blind, controlled phase 3 trial of fixed-dose brexpiprazole for the treatment of adults with acute schizophrenia

A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder

Efficacy and safety of flexibly dosed brexpiprazole for the adjunctive treatment of major depressive disorder: a randomized, active-referenced, placebo-controlled study

Efficacy and Safety of Brexpiprazole (OPC-34712) as Maintenance Treatment in Adults with Schizophrenia: a Randomized, Double-Blind, Placebo-Controlled Study

Outcomes of World Health Organization-defined Severe Respiratory Distress without Shock in Adults in Sub-Saharan Africa

Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy

A remote monitoring-enabled home exercise prescription for patients with interstitial lung disease at risk for exercise-induced desaturation

Suchergebnisse filtern